Additionally, Zhao et al., in a murine model, demonstrated sex differences in response to IL–33 treatment in IL–33-induced airway inflammation, and the authors found that type 2 inflammation induced by treatment with ovalbumin + IL–33 was more severe in female mice compared to males [46]. The gene discussed is IL33; the disease is inflammatory response.